Valeant Just Received 2 More Downgrades
March 21, 2016 at 09:14 AM EDT
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is down 73 percent year-to-date. It should come as little surprise, therefore, that the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.